ask="2.37"
ask_size="10000"
average_daily_volume="2788780"
bid="2.26"
bid_size="200"
book_value="4.53"
change="+0.03"
change_from_200_day_moving_average="-0.59"
change_from_50_day_moving_average="0.15"
change_from_52_week_high="-1.52"
change_From_52_week_low="0.39"
change_in_percent="+1.31%"
close="2.32"
dividend_pay_date="6/13/2016"
dividend_per_share="0.20"
dividend_yield="8.62"
earnings_per_share="1.06"
ebitda="244.51M"
eps_estimate_current_year="0.54"
eps_estimate_next_quarter="0.07"
eps_estimate_next_year="0.20"
ex_dividend_date="6/2/2016"
float_shares="149792000"
high="2.34"
high_52_weeks="3.84"
last_trade_date="1/24/2017"
last_trade_price="2.32"
last_trade_size="45103"
last_trade_time="4:00pm"
low="2.25"
low_52_weeks="1.93"
market_capitalization="384.05M"
moving_average_200_day="2.91"
moving_average_50_day="2.17"
name="PDL BioPharma
Inc."
notes="N/A"
one_year_target_price="3.67"
open="2.29"
pe_ratio="2.19"
peg_ratio="0.31"
percent_change_from_200_day_moving_average="-20.22%"
percent_change_from_50_day_moving_average="+6.72%"
percent_change_from_52_week_high="-39.58%"
percent_change_from_52_week_low="+20.21%"
previous_close="2.29"
price_eps_estimate_current_year="4.30"
price_eps_Estimate_next_year="11.60"
price_per_book="0.51"
price_per_sales="1.32"
revenue="286.16M"
shares_outstanding="165540000"
short_ratio="3.36"
stock_exchange="NMS"
symbol="PDLI"
volume="1753156"
weeks_range_52="1.93 - 3.84"
